(JAZZ) Jazz Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Jazz Pharmaceuticals | (JAZZ) share price targets
Complete technical analysis of Jazz Pharmaceuticals (JAZZ) by charts plus indicators, forecast predictions and share price targets for Jazz Pharmaceuticals (JAZZ)
Jazz Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-23 View latest technical analysis
10 day averaged volume of Jazz Pharmaceuticals is 735270
| Date | Daily Closing Price | Open | High | Low | Volume |
| 23 Mon Sep 2024 | 108.99 | 111.17 | 111.79 | 108.00 | 0.788 times |
| 20 Fri Sep 2024 | 110.76 | 110.81 | 111.45 | 109.43 | 2.714 times |
| 19 Thu Sep 2024 | 111.29 | 110.30 | 113.30 | 109.60 | 1.325 times |
| 18 Wed Sep 2024 | 109.57 | 111.52 | 112.09 | 108.99 | 0.624 times |
| 17 Tue Sep 2024 | 111.55 | 110.03 | 111.63 | 109.31 | 0.972 times |
| 16 Mon Sep 2024 | 109.57 | 110.00 | 110.55 | 109.34 | 0.661 times |
| 13 Fri Sep 2024 | 108.79 | 107.11 | 108.86 | 106.77 | 0.89 times |
| 12 Thu Sep 2024 | 106.45 | 105.17 | 107.71 | 104.62 | 0.816 times |
| 11 Wed Sep 2024 | 105.13 | 106.99 | 107.06 | 104.42 | 0.651 times |
| 10 Tue Sep 2024 | 107.10 | 106.68 | 107.31 | 105.51 | 0.653 times |
My analysis of stock is bearish for shortterm, and stock might move down till 106.9 or till 102.8. Use a stoploss of 110.4 and if the stock hits stoploss, then it can shoot up till 113.87
Share price targets for Jazz Pharmaceuticals (JAZZ)
| Target Type | Value |
| Downside Target | 99.06 |
| Downside Target | 103.01 |
| Upside Target | 111.79 |
| Upside Target | 113.30 |
| Upside Target | 113.60 |
| Upside Target | 113.96 |
| Upside Target | 114.86 |
| Upside Target | 115.24 |
| Upside Target | 116.55 |
| Upside Target | 117.77 |
Intraday share price targets for Jazz Pharmaceuticals (JAZZ)
| Target Type | Value |
| Downside Intraday Target | 107.4 |
| Downside Intraday Target | 105.8 |
| Upside Intraday Target | 111.19 |
| Upside Intraday Target | 113.38 |
| Upside Intraday Target | 109.59 |
Weekly technical analysis of Jazz Pharmaceuticals (JAZZ)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 23 Mon Sep 2024 | 108.99 | 111.17 | 111.79 | 108.00 | 0.125 times |
| 20 Fri Sep 2024 | 110.76 | 110.00 | 113.30 | 108.99 | 1.7 times |
| 13 Fri Sep 2024 | 108.79 | 107.44 | 108.86 | 104.42 | 0.341 times |
| 06 Fri Sep 2024 | 107.14 | 112.00 | 113.60 | 105.99 | 21.85 times |
| 30 Fri Aug 2024 | 115.98 | 115.54 | 116.55 | 114.86 | 0.189 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Jazz Pharmaceuticals (JAZZ)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 23 Mon Sep 2024 | 108.99 | 112.00 | 113.60 | 104.42 | 1.265 times |
| 30 Fri Aug 2024 | 115.98 | 113.15 | 117.77 | 107.27 | 1.031 times |
| 31 Wed Jul 2024 | 110.25 | 106.73 | 113.00 | 99.06 | 0.716 times |
| 28 Fri Jun 2024 | 106.73 | 105.25 | 115.24 | 104.27 | 0.89 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Jazz Pharmaceuticals (JAZZ)
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Jazz Pharmaceuticals in short term but the buy signal is initial and weak.
Jazz Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Jazz Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Jazz Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 109.49 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Jazz Pharmaceuticals in short term but the buy signal is initial and weak.
Jazz Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Jazz Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Jazz Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 109.49 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.